The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.
about
A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma.Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines.RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients.Role of RASSF1A promoter methylation in the pathogenesis of hepatocellular carcinoma: a meta-analysis of 21 cohort studies.Methylated RASSF1A in malignant peripheral nerve sheath tumors identifies neurofibromatosis type 1 patients with inferior prognosis.RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes.Clinical utility of RASSF1A methylation in human malignancies.Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastomaClinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates.Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma.Emerging gene-directed anti-tumor strategies against human hepatoblastoma.RASSF Signalling and DNA Damage: Monitoring the Integrity of the Genome?Genetics and epigenetics of hepatoblastoma.DNA methylation and apoptosis resistance in cancer cellsA cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese Study Group for Pediatric Liver Tumor (JPLT).ATM regulates a RASSF1A-dependent DNA damage response.Meiosis error and subsequent genetic and epigenetic alterations invoke the malignant transformation of germ cell tumor.Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.DNA methylation landscape of hepatoblastomas reveals arrest at early stages of liver differentiation and cancer-related alterations.BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy.Predicting hepatocellular carcinoma development for cirrhosis patients via methylation detection of heparocarcinogenesis-related genes.
P2860
Q30413809-156BCE08-1464-4796-BDC9-0B13EB521769Q34401887-89B82D7D-A8AB-42F7-BB47-19B7CBB4B420Q34976827-16133685-A388-4C66-ACF5-0663C263B23BQ35102439-54235F92-BF4F-4913-8D06-5DE5413282E6Q35558868-0E182933-A288-43C1-9569-8EC46E946687Q35891000-DB793E13-452E-4D31-9492-7E3CE12D8774Q35909621-D3B568C9-B9A0-402F-8646-9480E13F7A67Q37010551-580589AD-7F91-4374-A6E6-C46BF94C54AAQ37142441-43C380D9-D1E8-4EFA-9E7A-F60E5691806DQ37464602-4B846C5C-D054-4A36-9F53-BC8DD6ACBB60Q37571970-F55F8834-8849-479B-BE05-9808A2DD049FQ38009322-66DB3FE3-A8A9-4556-B827-DFF424FD0D19Q38027114-B6DD2130-3377-4717-A599-1228DC6450D0Q38202821-B2E7CBE5-6B21-41AE-A682-0784D3D840B0Q39351897-24D4D48E-A2E0-4CA0-84D6-CEB6D4CEE883Q39766802-6B170728-2BEF-465B-AB10-DE290636590CQ43566117-DD1151B2-0D6F-4319-A568-95B6DA3F1DB6Q45382726-A62D969C-EADA-478B-9B34-E02CAFA09B00Q47141495-FDA531B4-A165-4C68-AFBA-34EA7EC12DCFQ48309954-5DCC9F5C-2B79-4F7B-B2D2-98AD08CB92D5Q55345013-E59E314C-27F4-44E0-8AC8-95516F1BBA01
P2860
The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The methylation status of RASS ...... re in hepatoblastoma patients.
@en
The methylation status of RASS ...... re in hepatoblastoma patients.
@nl
type
label
The methylation status of RASS ...... re in hepatoblastoma patients.
@en
The methylation status of RASS ...... re in hepatoblastoma patients.
@nl
prefLabel
The methylation status of RASS ...... re in hepatoblastoma patients.
@en
The methylation status of RASS ...... re in hepatoblastoma patients.
@nl
P2093
P356
P1476
The methylation status of RASS ...... re in hepatoblastoma patients.
@en
P2093
Akira Nakagawara
Eiso Hiyama
Fumiaki Sasaki
Hiroaki Yamaoka
Hiroshi Horie
Masayuki Haruta
Miki Ohira
Naomi Ohnuma
Satoru Todo
Shohei Honda
P2860
P304
P356
10.1002/IJC.23613
P577
2008-09-01T00:00:00Z